Reversible severe myopathy during treatment with finasteride

Muscle and Nerve

Volumn 20, Issue 4, 1997, Pages 502-504

  Haan, Joost ^a,b   Hollander, Justus M R ^b   Van Duinen, Sjoerd G ^a   Saxena, Pramod R ^c   Wintzen, Axel R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

azasteroids; finasteride; myopathy; side effects

Indexed keywords

FINASTERIDE;

AGED; ARTICLE; ASTHENIA; CASE REPORT; DRUG WITHDRAWAL; HUMAN; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOPATHY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

EID: 0030900190     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4598(199704)20:4<502::aid-mus15>3.0.co;2-%23     Document Type: Article

References (6)

1. Carlin JR, Höglund P, Eriksson LO: Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. Drug Metab Dispos Biol Fate Chem 1992;20:148-155.
2. Case report of the Massachusetts General Hospital. N Engl J Med 1994;331:528-535.
3. Finasteride, in McEvoy GK (ed): American Hospital Formulary Service: Drug Information, Bethesda, MD, 1995, pp 2582-2584.
4. Kaminski HJ, Ruff RL: Endocrine myopathies, in Engel AG, Franzini-Armstrong C (eds): Myology. New York, McGraw-Hill, 1994, pp 1726-1753.
5. Rittmaster RS: Finasteride. N Engl J Med 1994;330:120-125.
6. Van Balkom RHH, Van Der Heijden HFM, Van Herwaarden CLA, Dekhuijzen PNR: Corticosteroid-induced myopathy of the respiratory muscles. Neth J Med 1994;45:114-122.